Somya Bansal

Somya’s areas of expertise span a broad range of actuarial and healthcare consulting domains, including:

• Conducting health reserving under Solvency II and UK GAAP, as well as pricing for insurance providers across the Middle East, UK, Europe, and Ireland
• Conducting SCR (Standard Formula or USP), Solvency II ORSA modelling and reporting
• Performing data analytics, including data quality assessment and evaluating suitability for advanced analytical applications
• Conducting regulatory support, including product approval processes in the Middle East and product reviews for UK-based insurers
• Developing cost-benefit models to evaluate local healthcare budgets and support public health initiatives
• Providing actuarial input in expert witness cases involving international medical expense premium estimation
• Auditing of PACE organisations and Pharmacy Benefit Managers, along with conducting Fraud, Waste, and Abuse (FWA) analysis for clients in the US
• Conducting M&A due diligence for health insurance firms

During her time at Milliman’s UK office, Somya was seconded to Bupa Global in 2022, where she contributed to the development of Solvency II Analysis of Variance (AvE), QRTs, and the automation of expert judgment processes. She was also seconded to AXA PPP’s risk team, where she supported premium reviews, risk management efforts, and climate change risk monitoring—particularly related to vector-borne diseases and heatwaves.